Aromatase inhibitors in male breast cancer: a pooled analysis

Flora Zagouri; Theodoros Ν. Sergentanis; Hatem A. Azim; Dimosthenis Chrysikos; Meletios A Dimopoulos; Θεοδώρα Ψαλτοπούλου

doi:10.1007/s10549-015-3356-9

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2014

Fulvestrant and male breast cancer: a pooled analysis

Flora Zagouri, Theodoros Ν. Sergentanis, Dimosthenis Chrysikos, Meletios A Dimopoulos, Θεοδώρα Ψαλτοπούλου

Article2013

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series

Flora Zagouri, Theodoros Ν. Sergentanis, Vassilis Koutoulidis, Cornelia Sparber, G.G. Steger, Peter Dubsky, Zografos Gc, Θεοδώρα Ψαλτοπούλου, Michael Gnant, Meletios A Dimopoulos, Rupert Bartsch

Article2006

Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis

Davide Mauri, Nicholas Pavlidis, Nikolaos P. Polyzos, John P A Ioannidis

Article2006

Survival benefit with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: Meta-analysis

Davide Mauri, Nikolaos P. Polyzos, John P A Ioannidis, Eleni Timotheadou, Nicholas Pavlidis

Article2007

Response: Re: Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis

John P A Ioannidis, Davide Mauri, Nikolaos P. Polyzos, Nicholas Pavlidis